Related Experiment Video

Updated: Jun 4, 2026

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab

Mathieu Leclerc, Jean-François Lesesve, Baptiste Gaillard

    Leukemia & Lymphoma
    |February 15, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
    06:36

    An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

    Published on: February 5, 2015

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
    09:41

    Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

    Published on: January 20, 2023

    An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
    06:36

    An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

    Published on: February 5, 2015

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

    Articles linked to this work by shared authors, journal, and citation graph.

    Climate-driven in-situ trait variation in an annual ruderal grass across Europe.

    Annals of botany·2026

    The t(X;5)(q13;q33) Translocation in Myeloid Neoplasms Is Preferentially Associated With Chronic Myelomonocytic Leukemia: A Report From the Groupe Francophone de Cytogénétique Hématologique.

    Genes, chromosomes & cancer·2026

    Toxocara seropositivity in sensory-predominant cervical myelitis from an endemic region: A six-case series and systematic review.

    Multiple sclerosis and related disorders·2026

    Practical Guidelines for Spinal Stereotactic Body Radiation Therapy Posttreatment Follow-Up: Empirical Consensus From Quebec Oncology Centers.

    Practical radiation oncology·2026

    Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

    Leukemia·2026

    Myelodysplastic syndrome with cryptic 5q deletions in young male patients showing sustained response to lenalidomide.

    Haematologica·2026

    Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.

    Leukemia & lymphoma·2026

    Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

    Leukemia & lymphoma·2026

    How to treat hepatic extra-medullary involvement of myeloma: a case report and review of literature.

    Leukemia & lymphoma·2026

    Effects of O-GlcNAc glycosylated modified transferase on prognosis of diffuse large B-cell lymphoma and analysis of downstream targets.

    Leukemia & lymphoma·2026

    Additional myelodysplasia-related gene mutations alter clinical presentation and worsen prognosis in patients with SRSF/TET2 co-mutated myeloid neoplasms.

    Leukemia & lymphoma·2026

    Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

    Leukemia & lymphoma·2026

    Blinatumomab administration in the outpatient setting: Safety and health care utilization.

    Cancer·2026

    Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

    Rheumatology (Oxford, England)·2026

    The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

    CNS neuroscience & therapeutics·2026

    Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

    Haematologica·2026

    Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

    Haematologica·2026

    Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

    Haematologica·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us